By Kiran Mazumdar-Shaw, CMD, Biocon The Lok Sabha elections in 2019 will be historic! An entire generation that was born at the turn of the 21st century will have turned 18 and thus become eligible to vote! 133 million young adults will get to exercise their franchise and thus give shape to their idea of … Continue reading It’s Time for India’s Youth to Stand Up and be Counted
The NDA government’s announcement of a health insurance scheme covering 500 million poor and needy Indians is indeed laudable. An estimated 75 million Indians are driven to bankruptcy and poverty each year because they have to pay over 60% of hospitalisation costs out of their own pockets. Given the dismal healthcare scenario, the NHPS can … Continue reading REALISING THE GAME CHANGING POTENTIAL OF NHPS
DATA IS KING In 2012, IDC projected that the digital universe will reach 40 zettabytes by 2020. This was based on the assumption that 1.7 megabytes of new information will be created every second for every human being on the planet in 2020. IDC realised that its projection was on the conservative side! Its current … Continue reading IHC Public Lecture: Strategic Importance Of Data Sciences In Research And Innovation
By Kiran Mazumdar Shaw The Finance Minister has presented a comprehensive and wide-ranging Budget for FY19, which addresses most of the areas that need focus to ensure sustainable, long-term and equitable growth of the Indian economy. The Union Budget needed to be prudent and forward-looking rather than populist and that is exactly what Finance Minister … Continue reading An Inclusive Budget
By Kiran Mazumdar Shaw, CMD, Biocon 2017 has been an exciting year for science in India. From unheralded incremental innovations to Big Bang headline-grabbing global feats, Indian scientists have done some very important work to push the frontiers of science during the year. India researchers made significant contributions to R&D across a broad spectrum of … Continue reading 2017 – A Landmark Year for Indian Science
By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance
Financial Chronicle: Big Interview: Biocon CMD Kiran Mazumdar-Shaw spoke to FC on a range of topics, including women as entrepreneurs, philanthropy, affordable healthcare, citizen activism etc. Here’s the full version of the interview. As a woman business leader, what are some of the challenges you have encountered in getting to the top and how were … Continue reading Crusader for Affordable Healthcare
Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon, tells P.B. Jayakumar about the key lessons she has learnt in business life.
The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s own rapidly advancing economy and rising global status. We have successfully leveraged recombinant DNA technology to deliver biopharmaceuticals, vaccines, genetically engineered crops and enzymes. In doing so, we have created a notable bio-economy valued at $35 billion. We have embraced … Continue reading India To Be A Biotech Hot Spot
Is India Inc.’s new found enthusiasm to have woman board members a reflection of changing mindsets or mere tokenism? Media reports suggest that more than 250 companies appointed women directors on Tuesday to meet the SEBI’s deadline. In fact, many companies have appointed wives, daughters and sisters of promoters and top company executives as directors … Continue reading Why Women on Board Make Smart Business Sense?